Remove 2022 Remove Competition Remove Leads
article thumbnail

FTC order could ease biopharma competition

European Pharmaceutical Review

to address the potential competitive harm Amgen’s $27.8 Consolidation in the pharmaceutical industry has given companies the power and incentive to engage in exclusionary rebating practices, which can lead to sky-rocketing prices on essential medications,” stated Henry Liu, Director of the FTC’s Bureau of Competition.

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. 2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review. Key areas of potential legislative change. Future outlook.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

149 Eye-Opening Sales Statistics to Consider in 2022 (By Category)

Spotio

Sales Prospecting Statistics The way companies prospect for leads is changing. HubSpot] 9 in 10 companies use 2+ lead enrichment tools to learn more about prospects. Invest in a toolset that allows you to quickly build profiles and find accurate lead data in your target market. With so much potential, comes a lot of competition.

Sales 111
article thumbnail

2022 Predictions From the Front-Lines of Pharma Digital Advertising

Pharma Marketing Network

Lewis, Founder & CEO of eHealthcare Solutions and Tap Native, offers his top ten predictions for what’s ahead for pharma in 2022. While large corporations with mega campuses will start to “return to campus” in 2022, if they haven’t already, few are drawing hard lines around a full-time return. In this article, R.J.

Pharma 105
article thumbnail

UnitedHealth-Walmart partnership heats up U.S. Medicare provider competition

Clarivate

The plans are profitable and continue to draw new Medicare enrollees, leading all top payers to make investments in retaining and attracting enrollees. Teaming with Walmart allows UnitedHealth to keep its leading position in the Medicare Advantage segment, where it holds the top market share with 7.9 2 Humana by more than 2.5

article thumbnail

2022 Sales Hiring Forecast

Sales Talent

Although none of these resources give a sales-specific hiring forecast, there is enough information between them to accurately predict sales hiring for 2022. Our prior sales forecast for 2021 predicted that “competition for talent should become intense in the latter half of 2021.” 2022 Sales Forecast for Hiring.

Sales 52
article thumbnail

Eli Lilly achieving significant gains in obesity results

Pharmaceutical Technology

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson. There have been several Phase III trials for Mounjaro, with SURMOUNT-1 demonstrating a weight loss of up to 22.5%

Leads 98